These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 18688878)

  • 1. Genotype-specific interactions of insulin resistance, steatosis, and fibrosis in chronic hepatitis C.
    Cua IH; Hui JM; Kench JG; George J
    Hepatology; 2008 Sep; 48(3):723-31. PubMed ID: 18688878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of insulin resistance on hepatic fibrosis and steatosis in hepatitis C virus (HCV) mono-infected compared with HIV-HCV co-infected patients.
    Halfon P; Pénaranda G; Carrat F; Bedossa P; Bourlière M; Ouzan D; Renou C; Tran A; Rosenthal E; Wartelle C; Delasalle P; Cacoub P
    Aliment Pharmacol Ther; 2009 Jul; 30(1):61-70. PubMed ID: 19292832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis.
    Moucari R; Asselah T; Cazals-Hatem D; Voitot H; Boyer N; Ripault MP; Sobesky R; Martinot-Peignoux M; Maylin S; Nicolas-Chanoine MH; Paradis V; Vidaud M; Valla D; Bedossa P; Marcellin P
    Gastroenterology; 2008 Feb; 134(2):416-23. PubMed ID: 18164296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin resistance: a major factor associated with significant liver fibrosis in Egyptian patients with genotype 4 chronic hepatitis C.
    El Ray A; Asselah T; Moucari R; El Ghannam M; Taha AA; Saber MA; Akl M; Atta R; Shemis M; Radwan AS; Ghali A; Paradis V; Marcellin P
    Eur J Gastroenterol Hepatol; 2013 Apr; 25(4):421-7. PubMed ID: 23470266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interplay between oxidative stress and hepatic steatosis in the progression of chronic hepatitis C.
    Vidali M; Tripodi MF; Ivaldi A; Zampino R; Occhino G; Restivo L; Sutti S; Marrone A; Ruggiero G; Albano E; Adinolfi LE
    J Hepatol; 2008 Mar; 48(3):399-406. PubMed ID: 18164507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis C.
    Fartoux L; Poujol-Robert A; Guéchot J; Wendum D; Poupon R; Serfaty L
    Gut; 2005 Jul; 54(7):1003-8. PubMed ID: 15951550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin resistance and liver injury in hepatitis C is not associated with virus-specific changes in adipocytokines.
    Cua IH; Hui JM; Bandara P; Kench JG; Farrell GC; McCaughan GW; George J
    Hepatology; 2007 Jul; 46(1):66-73. PubMed ID: 17596870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic steatosis and insulin resistance are associated with serum imbalance of adiponectin/tumour necrosis factor-alpha in chronic hepatitis C patients.
    Durante-Mangoni E; Zampino R; Marrone A; Tripodi MF; Rinaldi L; Restivo L; Cioffi M; Ruggiero G; Adinolfi LE
    Aliment Pharmacol Ther; 2006 Nov; 24(9):1349-57. PubMed ID: 17059516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: Role of insulin resistance and hepatic steatosis.
    Bugianesi E; Marchesini G; Gentilcore E; Cua IH; Vanni E; Rizzetto M; George J
    Hepatology; 2006 Dec; 44(6):1648-55. PubMed ID: 17133473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-load insulin resistance is an independent predictor of hepatic fibrosis in virus C chronic hepatitis and in non-alcoholic fatty liver disease.
    Svegliati-Baroni G; Bugianesi E; Bouserhal T; Marini F; Ridolfi F; Tarsetti F; Ancarani F; Petrelli E; Peruzzi E; Lo Cascio M; Rizzetto M; Marchesini G; Benedetti A
    Gut; 2007 Sep; 56(9):1296-301. PubMed ID: 17392334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin resistance and diabetes increase fibrosis in the liver of patients with genotype 1 HCV infection.
    Petta S; Cammà C; Di Marco V; Alessi N; Cabibi D; Caldarella R; Licata A; Massenti F; Tarantino G; Marchesini G; Craxì A
    Am J Gastroenterol; 2008 May; 103(5):1136-44. PubMed ID: 18477344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin resistance is associated with steatosis in nondiabetic patients with genotype 1 chronic hepatitis C.
    Cammà C; Bruno S; Di Marco V; Di Bona D; Rumi M; Vinci M; Rebucci C; Cividini A; Pizzolanti G; Minola E; Mondelli MU; Colombo M; Pinzello G; Craxì A
    Hepatology; 2006 Jan; 43(1):64-71. PubMed ID: 16374856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucose intolerance and hypoadiponectinemia are already present in lean patients with chronic hepatitis C infected with genotype non-3 viruses.
    Anty R; Gelsi E; Giudicelli J; Mariné-Barjoan E; Gual P; Benzaken S; Saint-Paul MC; Sadoul JL; Huet PM; Tran A
    Eur J Gastroenterol Hepatol; 2007 Aug; 19(8):671-7. PubMed ID: 17625437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C virus-associated hypobetalipoproteinemia is correlated with plasma viral load, steatosis, and liver fibrosis.
    Petit JM; Benichou M; Duvillard L; Jooste V; Bour JB; Minello A; Verges B; Brun JM; Gambert P; Hillon P
    Am J Gastroenterol; 2003 May; 98(5):1150-4. PubMed ID: 12809841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis C.
    Miquilena-Colina ME; Lima-Cabello E; Sánchez-Campos S; García-Mediavilla MV; Fernández-Bermejo M; Lozano-Rodríguez T; Vargas-Castrillón J; Buqué X; Ochoa B; Aspichueta P; González-Gallego J; García-Monzón C
    Gut; 2011 Oct; 60(10):1394-402. PubMed ID: 21270117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of serum adipocytokines with insulin resistance and liver injury in patients with chronic hepatitis C genotype 4.
    Khattab MA; Eslam M; Aly MM; Shatat M; Hussen A; Moussa YI; Elsaghir G; Abdalhalim H; Aly A; Gaber S; Harrison SA
    J Clin Gastroenterol; 2012; 46(10):871-9. PubMed ID: 22664476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High hepatitis C viral load is associated with insulin resistance in patients with chronic hepatitis C.
    Hsu CS; Liu CJ; Liu CH; Wang CC; Chen CL; Lai MY; Chen PJ; Kao JH; Chen DS
    Liver Int; 2008 Feb; 28(2):271-7. PubMed ID: 18028320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum HCV RNA levels and HCV genotype do not affect insulin resistance in nondiabetic patients with chronic hepatitis C: a multicentre study.
    Tsochatzis E; Manolakopoulos S; Papatheodoridis GV; Hadziyannis E; Triantos C; Zisimopoulos K; Goulis I; Tzourmakliotis D; Akriviadis E; Manesis EK; Archimandritis AJ
    Aliment Pharmacol Ther; 2009 Nov; 30(9):947-54. PubMed ID: 19604179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time course of insulin resistance during antiviral therapy in non-diabetic, non-cirrhotic patients with genotype 1 HCV infection.
    Petta S; Cammà C; Di Marco V; Cabibi D; Ciminnisi S; Caldarella R; Licata A; Massenti MF; Marchesini G; Craxì A
    Antivir Ther; 2009; 14(5):631-9. PubMed ID: 19704165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity.
    Adinolfi LE; Gambardella M; Andreana A; Tripodi MF; Utili R; Ruggiero G
    Hepatology; 2001 Jun; 33(6):1358-64. PubMed ID: 11391523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.